Workshop statement on the essentiality of and recommended dietary intakes for Omega-6 and Omega-3 fatty acids, Prostaglandins Leukot Essent Fatty Acids, vol.63, pp.119-121, 2000. ,
Neuroprotective action of omega-3 polyunsaturated fatty acids against neurodegenerative diseases: evidence from animal studies, Prostaglandins Leukot Essent Fatty Acids, vol.77, pp.287-293, 2007. ,
Polyunsaturated fatty acids and their metabolites in brain function and disease, Nat Rev Neurosci, vol.15, pp.771-785, 2014. ,
URL : https://hal.archives-ouvertes.fr/hal-02640592
Anandamide and diet: inclusion of dietary arachidonate and docosahexaenoate leads to increased brain levels of the corresponding N-acylethanolamines in piglets, Proc Natl Acad Sci USA, vol.98, pp.6402-6406, 2001. ,
Polyunsaturated fatty acid (PUFA) deficiency elevates and n-3 PUFA enrichment reduces brain 2-arachidonoylglycerol level in mice, Prostaglandins Leukot Essent Fatty Acids, vol.69, pp.51-59, 2003. ,
,
Maternal care differentially affects neuronal excitability and synaptic plasticity in the dorsal and ventral hippocampus, Neuropsychopharmacology, vol.40, pp.1590-1599, 2015. ,
Dietary omega 3 fatty acids and the developing brain, Brain Res, vol.1237, pp.35-43, 2008. ,
Brain metabolism of nutritionally essential polyunsaturated fatty acids depends on both the diet and the liver, Prostaglandins Leukot Essent Fatty Acids, vol.77, pp.251-261, 2007. ,
n-3 LCPUFA improves cognition: the young, the old and the sick, Prostaglandins Leukot Essent Fatty Acids, vol.91, pp.1-20, 2014. ,
URL : https://hal.archives-ouvertes.fr/hal-02639255
Dietary n-3 PUFA deprivation alters expression of enzymes of the arachidonic and docosahexaenoic acid cascades in rat frontal cortex, Mol Psychiatry, vol.12, pp.151-157, 2007. ,
Brain phospholipid arachidonic acid half-lives are not altered following 15 weeks of N-3 polyunsaturated fatty acid adequate or deprived diet, J Lipid Res, vol.51, pp.535-543, 2010. ,
Long term adequate n-3 polyunsaturated fatty acid diet protects from depressive-like behavior but not from working memory disruption and brain cytokine expression in aged mice, Brain Behav Immun, vol.26, pp.721-731, 2012. ,
URL : https://hal.archives-ouvertes.fr/hal-02647840
Dietary n-6 polyunsaturated fatty acid deprivation increases docosahexaenoic acid metabolism in rat brain, J Neurochem, vol.120, pp.985-997, 2012. ,
Nutritional n-3 PUFAs deficiency during perinatal periods alters brain innate immune system and neuronal plasticity-associated genes, Brain Behav Immun, vol.41, pp.22-31, 2014. ,
URL : https://hal.archives-ouvertes.fr/hal-02640850
A neuroscientist's guide to lipidomics, Nat Rev Neurosci, vol.8, pp.743-754, 2007. ,
Polyunsaturated phospholipids facilitate membrane deformation and fission by endocytic proteins, Science, vol.345, pp.693-697, 2014. ,
URL : https://hal.archives-ouvertes.fr/hal-01141794
Lipid signaling: sleep, synaptic plasticity, and neuroprotection, Prostaglandins Other Lipid Mediat, vol.77, pp.65-76, 2005. ,
Pro-resolving lipid mediators are leads for resolution physiology, Nature, vol.510, pp.92-101, 2014. ,
Eicosanoid storm in infection and inflammation, Nat Rev Immunol, vol.15, pp.511-523, 2015. ,
Mechanisms of action of docosahexaenoic acid in the nervous system, Lipids, vol.36, pp.945-959, 2001. ,
Endocannabinoid signaling and synaptic function, Neuron, vol.76, pp.70-81, 2012. ,
Inhibition of neuronal apoptosis by docosahexaenoic acid, J Biol Chem, vol.22, pp.35215-35223, 2000. ,
Docosahexaenoic acid promotes neurite growth in hippocampal neurons, J Neurochem, vol.90, pp.979-988, 2004. ,
A synaptogenic amide N-docosahexaenoylethanolamide promotes hippocampal development, Prostaglandins Other Lipid Mediat, vol.96, 2011. ,
A role for docosahexaenoic acid-derived neuroprotectin D1 in neural cell survival and Alzheimer disease, J Clin Invest, vol.115, pp.2774-2783, 2005. ,
The docosanoid neuroprotectin D1 induces homeostatic regulation of neuroinflammation and cell survival, Prostaglandins Leukot Essent Fatty Acids, vol.88, pp.127-129, 2013. ,
Dietary omega-3 fatty acids normalize BDNF levels, reduce oxidative damage, and counteract learning disability after traumatic brain injury in rats, J Neurotrauma, vol.21, pp.1457-1467, 2004. ,
Omega-3 polyunsaturated fatty acids in Alzheimer's disease: key questions and partial answers, Curr Alzheimer Res, vol.8, pp.470-478, 2011. ,
docosahexaenoic acid and Alzheimer's disease, Prog Lipid Res, vol.48, pp.239-256, 2009. ,
Dietary fat intake, pesticide use, and Parkinson's disease, Parkinsonism Relat Disord, vol.20, pp.82-87, 2014. ,
Inflammation as a predictive biomarker for response to omega-3 fatty acids in major depressive disorder: a proof-of-concept study, Mol Psychiatry, vol.21, pp.71-79, 2016. ,
,
Dietary n-3 PUFAs deficiency increases vulnerability to inflammation-induced spatial memory impairment, Neuropsychopharmacology, vol.40, pp.2774-2787, 2015. ,
URL : https://hal.archives-ouvertes.fr/hal-02640350
Short-term long chain omega3 diet protects from neuroinflammatory processes and memory impairment in aged mice, PLoS ONE, vol.7, p.36861, 2012. ,
URL : https://hal.archives-ouvertes.fr/hal-01191175
Transgenic increase in n-3/n-6 fatty acid ratio protects against cognitive deficits induced by an immune challenge through decrease of neuroinflammation, Neuropsychopharmacology, vol.40, pp.525-536, 2015. ,
URL : https://hal.archives-ouvertes.fr/hal-02635645
Endocannabinoid signaling and long-term synaptic plasticity, Annu Rev Physiol, vol.71, pp.283-306, 2009. ,
Metabolism of endocannabinoids and related N-acylethanolamines: canonical and alternative pathways, FEBS J, vol.280, pp.1874-1894, 2013. ,
More surprises lying ahead. The endocannabinoids keep us guessing, Neuropharmacology, vol.76, pp.228-234, 2014. ,
Metabotropic glutamate receptor 2/3-dependent long-term depression in the nucleus accumbens is blocked in morphine withdrawn mice, Eur J Neurosci, vol.16, pp.2231-2235, 2002. ,
Role of p/q-Ca2+ channels in metabotropic glutamate receptor 2/3-dependent presynaptic long-term depression at nucleus accumbens synapses, J Neurosci, vol.22, pp.4346-4356, 2002. ,
Distinct coincidence detectors govern the corticostriatal spike timing-dependent plasticity, J Physiol (Lond), vol.588, pp.3045-3062, 2010. ,
URL : https://hal.archives-ouvertes.fr/hal-02407307
The endocannabinoid 2-arachidonoylglycerol produced by diacylglycerol lipase alpha mediates retrograde suppression of synaptic transmission, Neuron, vol.65, pp.320-327, 2010. ,
The diacylglycerol lipases: structure, regulation and roles in and beyond endocannabinoid signalling, Philos Trans R Soc Lond, B, Biol Sci, vol.367, pp.3264-3275, 2012. ,
Endocannabinoid transport revisited, Vitam Horm, vol.98, pp.441-485, 2015. ,
Enzymatic pathways that regulate endocannabinoid signaling in the nervous system, Chem Rev, vol.108, pp.1687-1707, 2008. ,
Complementary synaptic distribution of enzymes responsible for synthesis and inactivation of the endocannabinoid 2-arachidonoylglycerol in the human hippocampus, Neuroscience, vol.174, pp.50-63, 2011. ,
Metabolic Interplay between astrocytes and neurons regulates endocannabinoid action, Cell Rep, vol.12, pp.798-808, 2015. ,
PUFA-derived endocannabinoids: an overview, Proc Nutr Soc, vol.72, pp.451-459, 2013. ,
COX-2-derived endocannabinoid metabolites as novel inflammatory mediators, Trends Pharmacol Sci, vol.35, pp.284-292, 2014. ,
Substrate-selective COX-2 inhibition as a novel strategy for therapeutic endocannabinoid augmentation, Trends Pharmacol Sci, vol.35, pp.358-367, 2014. ,
Identification of biosynthetic precursors for the endocannabinoid anandamide in the rat brain, J Lipid Res, vol.49, pp.48-57, 2008. ,
A catalytically silent FAAH-1 variant drives anandamide transport in neurons, Nat Neurosci, vol.15, pp.64-69, 2012. ,
Role of FAAH-like anandamide transporter in anandamide inactivation, PLoS ONE, vol.8, p.79355, 2013. ,
Why do cannabinoid receptors have more than one endogenous ligand, Philos Trans R Soc Lond B Biol Sci, vol.367, pp.3216-3228, 2012. ,
Biochemistry and pharmacology of endovanilloids, Pharmacol Ther, vol.114, pp.13-33, 2007. ,
Anandamide and the vanilloid receptor (TRPV1) ,
, Vitam Horm, vol.81, pp.389-419, 2009.
Postsynaptic TRPV1 triggers cell type-specific long-term depression in the nucleus accumbens, Nat Neurosci, vol.13, pp.1519-1525, 2010. ,
TRPV1 activation by endogenous anandamide triggers postsynaptic long-term depression in dentate gyrus, Nat Neurosci, vol.13, pp.1511-1518, 2010. ,
Polymodal activation of the endocannabinoid system in the extended amygdala, Nat Neurosci, vol.14, pp.1542-1547, 2011. ,
URL : https://hal.archives-ouvertes.fr/hal-01160051
Membrane microdomains and metabolic pathways that define anandamide and 2-arachidonyl glycerol biosynthesis and breakdown, Neuropharmacology, vol.55, pp.1095-1104, 2008. ,
therapeutic opportunities from regulating endocannabinoid levels, Curr Opin Investig Drugs, vol.11, pp.51-62, 2010. ,
The potential of inhibitors of endocannabinoid metabolism for drug development: a critical review, Handb Exp Pharmacol, vol.231, pp.95-128, 2015. ,
Fatty acid amide hydrolase inhibitors: a patent review, Expert Opin Ther Pat, vol.25, pp.1247-1266, 2009. ,
Loss of retrograde endocannabinoid signaling and reduced adult neurogenesis in diacylglycerol lipase knock-out mice, J Neurosci, vol.30, pp.2017-2024, 2010. ,
Inactivation of N-acyl phosphatidylethanolamine phospholipase D reveals multiple mechanisms for the biosynthesis of endocannabinoids, Biochemistry, vol.45, pp.4720-4726, 2006. ,
Enzymatic formation of N-acylethanolamines from N-acylethanolamine plasmalogen through Nacylphosphatidylethanolamine-hydrolyzing phospholipase D-dependent andindependent pathways, Biochim Biophys Acta, vol.1811, pp.565-577, 2011. ,
Dietary docosahexaenoic acid supplementation alters select physiological endocannabinoid-system metabolites in brain and plasma, J Lipid Res, vol.51, pp.1416-1423, 2010. ,
Structural requirements for binding of anandamide-type compounds to the brain cannabinoid receptor, J Med Chem, vol.40, pp.659-667, 1997. ,
Acyl amines of docosahexaenoic acid and other n-3 polyunsatured fatty acids-from fishy endocannabinoids to potential leads, Br J Pharmacol, vol.169, pp.772-783, 2013. ,
Synaptamide, endocannabinoid-like derivative of docosahexaenoic acid with cannabinoid-independent function, Prostaglandins Leukot Essent Fatty Acids, vol.88, pp.121-125, 2013. ,
Docosahexaenoic acid promotes hippocampal neuronal development and synaptic function, J Neurochem, vol.111, pp.510-521, 2009. ,
Biosynthesis and inactivation of N-arachidonoylethanolamine (anandamide) and N-docosahexaenoylethanolamine in bovine retina, Arch Biochem Biophys, vol.370, pp.300-307, 1999. ,
Dietinduced changes in n-3-and n-6-derived endocannabinoids and reductions in headache pain and psychological distress, J Pain, vol.16, pp.707-716, 2015. ,
Effect of dietary krill oil supplementation on the endocannabinoidome of metabolically relevant tissues from high-fat-fed mice, Nutr Metab (Lond), vol.8, p.51, 2011. ,
Fish oil and inflammatory status alter the n-3 to n-6 balance of the endocannabinoid and oxylipin metabolomes in mouse plasma and tissues, Metabolomics, vol.8, pp.1130-1147, 2012. ,
Effect of polyunsaturated fatty acids on endocannabinoid and N-acyl-ethanolamine levels in mouse adipocytes, Biochim Biophys Acta, vol.1781, pp.52-60, 2008. ,
Endocannabinoids may mediate the ability of (n-3) fatty acids to reduce ectopic fat and inflammatory mediators in obese Zucker rats, J Nutr, vol.139, pp.1495-1501, 2009. ,
Dietary linoleic acid elevates endogenous 2-AG and anandamide and induces obesity, Obesity (Silver Spring), vol.20, pp.1984-1994, 2012. ,
Dietary linoleic acid elevates the endocannabinoids 2-AG and anandamide and promotes weight gain in mice fed a low fat diet, Lipids, vol.49, pp.59-69, 2014. ,
,
Dietary DHA reduces downstream endocannabinoid and inflammatory gene expression and epididymal fat mass while improving aspects of glucose use in muscle in C57BL/6J mice, Int J Obes (Lond), vol.40, pp.129-137, 2016. ,
Effect of different dietary omega-3/omega-6 fatty acid ratios on reproduction in male rats, Lipids Health Dis, vol.12, p.33, 2013. ,
Effect of dietary fat on endocannabinoids and related mediators: consequences on energy homeostasis, inflammation and mood, Mol Nutr Food Res, vol.54, pp.82-92, 2010. ,
The endocannabinoid system: pivotal orchestrator of obesity and metabolic disease, Trends Endocrinol Metab, vol.26, pp.524-537, 2015. ,
Care and feeding of the endocannabinoid system: a systematic review of potential clinical interventions that upregulate the endocannabinoid system, PLoS ONE, vol.9, p.89566, 2014. ,
Metabolic responses to long-term pharmacological inhibition of CB1-receptor activity in mice in relation to dietary fat composition, Int J Obes (Lond), vol.34, pp.374-384, 2010. ,
Endocannabinoid signaling in innate and adaptive immunity, Immunology, 2015. ,
Polyunsaturated fatty acids and inflammation, IUBMB Life, vol.67, pp.659-667, 2015. ,
URL : https://hal.archives-ouvertes.fr/hal-01959545
Lipid signaling in adipose tissue: connecting inflammation & metabolism, Biochim Biophys Acta, vol.1851, pp.503-518, 2015. ,
The endocannabinoid signaling system: a marriage of PUFA and musculoskeletal health, J Nutr Biochem, vol.21, pp.1141-1152, 2010. ,
Eicosapentaenoic acid decreases expression of anandamide synthesis enzyme and cannabinoid receptor 2 in osteoblast-like cells, J Nutr Biochem, vol.22, pp.195-200, 2011. ,
Endocannabinoid system as a potential mechanism for n-3 long-chain polyunsaturated fatty acid mediated cardiovascular protection, Proc Nutr Soc, vol.72, pp.460-469, 2013. ,
Cardioprotective mechanism of omega-3 polyunsaturated fatty acids, J Cardiol, vol.67, pp.22-27, 2016. ,
The role of endocannabinoids in gonadal function and fertility along the evolutionary axis, Mol Cell Endocrinol, vol.355, pp.1-14, 2012. ,
Updates in reproduction coming from the endocannabinoid system, Int J Endocrinol, p.412354, 2014. ,
Endocannabinoids are involved in male vertebrate reproduction: regulatory mechanisms at central and gonadal level, Front Endocrinol (Lausanne), vol.5, p.54, 2014. ,
Polyunsaturated fatty acid derived signaling in reproduction and development: insights from Caenorhabditis elegans and Drosophila melanogaster, Mol Reprod Dev, vol.80, pp.244-259, 2013. ,
Imbalanced lipid homeostasis in the conditional Dicer1 knockout mouse epididymis causes instability of the sperm membrane, FASEB J, vol.29, pp.433-442, 2015. ,
Some subtypes of endocannabinoid/endovanilloid receptors mediate docosahexaenoic acidinduced enhanced spatial memory in rats, Brain Res, vol.1412, pp.18-27, 2011. ,
Modulation of fear memory by dietary polyunsaturated fatty acids via cannabinoid receptors, Neuropsychopharmacology, vol.39, pp.1852-1860, 2014. ,
Ligand-induced down-regulation of the cannabinoid 1 receptor is mediated by the G-protein-coupled receptor-associated sorting protein GASP1, FASEB J, vol.21, pp.802-811, 2007. ,
The cannabinoid type-1 receptor carboxyl-terminus, more than just a tail, J Neurochem, vol.117, pp.1-18, 2011. ,
Brain regional differences in CB1 receptor adaptation and regulation of transcription, Life Sci, vol.92, pp.446-452, 2013. ,
Functional diversity on synaptic plasticity mediated by endocannabinoids, Philos Trans R Soc Lond, B, Biol Sci, vol.367, pp.3242-3253, 2012. ,
,
Stress switches cannabinoid type-1 (CB1) receptor-dependent plasticity from LTD to LTP in the bed nucleus of the stria terminalis, J Neurosci, vol.33, pp.19657-19663, 2013. ,
URL : https://hal.archives-ouvertes.fr/hal-01160039
Endocannabinoids mediate bidirectional striatal spike-timing-dependent plasticity, J Physiol (Lond), vol.593, pp.2833-2849, 2015. ,
URL : https://hal.archives-ouvertes.fr/hal-01141205
n-3 fatty acids: role in neurogenesis and neuroplasticity, Curr Med Chem, vol.20, pp.2953-2963, 2013. ,
Omega-3 fatty acids can reverse the long-term deficits in hippocampal synaptic plasticity caused by prenatal ethanol exposure, Neurosci Lett, vol.551, pp.7-11, 2013. ,
Dietary intake of unsaturated fatty acids modulates physiological properties of entorhinal cortex neurons in mice, J Neurochem, vol.122, pp.427-443, 2012. ,
Omega-3 fatty acids deficiency aggravates glutamatergic synapse and astroglial aging in the rat hippocampal CA1, Aging Cell, vol.12, pp.76-84, 2013. ,
URL : https://hal.archives-ouvertes.fr/hal-02325139
Lipid rafts: a nexus for endocannabinoid signaling?, Life Sci, vol.77, pp.1640-1650, 2005. ,
Lipids, lipid rafts and caveolae: their importance for GPCR signaling and their centrality to the endocannabinoid system, Life Sci, vol.77, pp.1625-1639, 2005. ,
Lipid rafts regulate 2-arachidonoylglycerol metabolism and physiological activity in the striatum, J Neurochem, vol.109, pp.371-381, 2009. ,
Lipid rafts as a membrane-organizing principle, Science, vol.327, pp.46-50, 2010. ,
Lipid rafts in the maintenance of synapses, dendritic spines, and surface AMPA receptor stability, J Neurosci, vol.23, pp.3262-3271, 2003. ,
Polyunsaturated fatty acid-cholesterol interactions: domain formation in membranes, Biochim Biophys Acta, vol.1788, pp.24-32, 2009. ,
Docosahexaenoic acid domains: the ultimate non-raft membrane domain, Chem Phys Lipids, vol.153, pp.57-63, 2008. ,
Biophysical and biochemical mechanisms by which dietary N-3 polyunsaturated fatty acids from fish oil disrupt membrane lipid rafts, J Nutr Biochem, vol.23, pp.101-105, 2012. ,
Updated systematic review and meta-analysis of the effects of n-3 long-chain polyunsaturated fatty acids on depressed mood, Am J Clin Nutr, vol.91, pp.757-770, 2010. ,
A meta-analytic review of polyunsaturated fatty acid compositions in patients with depression, Biol Psychiatry, vol.68, pp.140-147, 2010. ,
Selective deficits in the omega-3 fatty acid docosahexaenoic acid in the postmortem orbitofrontal cortex of patients with major depressive disorder, Biol Psychiatry, vol.62, pp.17-24, 2007. ,
Lower docosahexaenoic acid concentrations in the postmortem prefrontal cortex of adult depressed suicide victims compared with controls without cardiovascular disease, J Psychiatr Res, vol.47, pp.1187-1191, 2013. ,
Review of nutritional supplements for the treatment of bipolar depression, Depress Anxiety, vol.31, pp.379-390, 2014. ,
Omega-3 fatty acid augmentation of citalopram treatment for patients with major depressive disorder, J Clin Psychopharmacol, vol.32, pp.61-64, 2012. ,
Phospholipid supplementation reverses behavioral and biochemical alterations induced by n-3 polyunsaturated fatty acid deficiency in mice, J Lipid Res, vol.41, pp.473-480, 2000. ,
Nutritional omega-3 modulates neuronal morphology in the prefrontal cortex along with depression-related behaviour through corticosterone secretion, Transl Psychiatry, vol.4, p.437, 2014. ,
URL : https://hal.archives-ouvertes.fr/hal-02635379
N-3 (omega-3) polyunsaturated Fatty acids in the pathophysiology and treatment of depression: pre-clinical evidence, CNS Neurol Disord Drug Targets, vol.12, pp.450-459, 2013. ,
PUFA induce antidepressant-like effects in parallel to structural and molecular changes in the hippocampus, Psychoneuroendocrinology, vol.34, pp.199-211, 2009. ,
Chronic ?-3 fatty acids supplementation promotes beneficial effects on anxiety, cognitive and Dietary Omega-6/Omega-3 and Endocannabinoids: Implications for Brain Health and Diseases ,
, depressive-like behaviors in rats subjected to a restraint stress protocol, Behav Brain Res, vol.219, pp.116-122, 2011.
Putative role of endocannabinoid signaling in the etiology of depression and actions of antidepressants, Prog Neuropsychopharmacol Biol Psychiatry, vol.35, pp.1575-1585, 2011. ,
CB1 receptor-deficient mice as a model for depression, Neuroscience, vol.204, pp.193-206, 2012. ,
Central anandamide deficiency predicts stress-induced anxiety: behavioral reversal through endocannabinoid augmentation, Transl Psychiatry, vol.4, p.408, 2014. ,
Chronic stress induces anxiety via an amygdalar intracellular cascade that impairs endocannabinoid signaling, Neuron, vol.85, pp.1319-1331, 2015. ,
Repeated homotypic stress elevates 2-arachidonoylglycerol levels and enhances short-term endocannabinoid signaling at inhibitory synapses in basolateral amygdala, Neuropsychopharmacology, vol.34, pp.2699-2709, 2009. ,
Differential effects of chronic unpredictable stress on hippocampal CB1 receptors in male and female rats, Behav Brain Res, vol.203, pp.264-269, 2009. ,
Deficiency in endocannabinoid signaling in the nucleus accumbens induced by chronic unpredictable stress, Neuropsychopharmacology, vol.35, pp.2249-2261, 2010. ,
Reversible gating of endocannabinoid plasticity in the amygdala by chronic stress: a potential role for monoacylglycerol lipase inhibition in the prevention of stress-induced behavioral adaptation, Neuropsychopharmacology, vol.36, pp.2750-2761, 2011. ,
Circulating endocannabinoids and N-acyl ethanolamines are differentially regulated in major depression and following exposure to social stress, Psychoneuroendocrinology, vol.34, pp.1257-1262, 2009. ,
Enhancement of endocannabinoid signaling and the pharmacotherapy of depression, Pharmacol Res, vol.56, pp.360-366, 2007. ,
Translational evidence for the involvement of the endocannabinoid system in stress-related psychiatric illnesses, Biol Mood Anxiety Disord, vol.3, p.19, 2013. ,
Nutritional Omega-3 deficiency alters glucocorticoid receptor-signaling pathway and neuronal morphology in regionally distinct brain structures associated with emotional deficits, nutritional Omega-3 deficiency alters glucocorticoid receptor-signaling pathway and neuronal morphology in regionally distinct brain structures associated with emotional deficits, Neural Plast, vol.2016, p.8574830, 2015. ,
Glucocorticoids shift arachidonic acid metabolism toward endocannabinoid synthesis: a non-genomic anti-inflammatory switch, Eur J Pharmacol, vol.583, pp.322-339, 2008. ,
Endocannabinoid signaling negatively modulates stress-induced activation of the hypothalamicpituitary-adrenal axis, Endocrinology, vol.145, pp.5431-5438, 2004. ,
The therapeutic potential of cannabinoids for movement disorders, Mov Disord, vol.30, pp.313-327, 2015. ,
Docosahexaenoic acid provides protective mechanism in bilaterally MPTP-lesioned rat model of Parkinson's disease, Folia Histochem Cytobiol, vol.50, pp.228-238, 2012. ,
Isotopic reinforcement of essential polyunsaturated fatty acids diminishes nigrostriatal degeneration in a mouse model of Parkinson's disease, Toxicol Lett, vol.207, pp.97-103, 2011. ,
The effects of docosahexaenoic acid on glial derived neurotrophic factor and neurturin in bilateral rat model of Parkinson's disease, Folia Histochem Cytobiol, vol.48, pp.434-441, 2010. ,
Transgenic conversion of omega-6 into omega-3 fatty acids in a mouse model of Parkinson's disease, J Lipid Res, vol.52, pp.263-271, 2011. ,
Impact of ?-3 fatty acids in Parkinson's disease, Ageing Res Rev, vol.10, pp.453-463, 2011. ,
Dietary fat intake and risk for Parkinson's disease, Mov Disord, vol.29, pp.1623-1630, 2014. ,
Docosahexaenoic acid protects from dendritic pathology in an Alzheimer's disease mouse model, Neuron, vol.43, pp.633-645, 2004. ,
Dietary n-3 polyunsaturated fatty acid depletion activates caspases and decreases NMDA receptors in the Dietary Omega-6/Omega-3 and Endocannabinoids: Implications for Brain Health and Diseases ,
, Alzheimer's disease, Eur J Neurosci, vol.22, pp.617-626, 2005.
Docosahexaenoic acid homeostasis, brain aging and Alzheimer's disease: can we reconcile the evidence?, Prostaglandins Leukot Essent Fatty Acids, vol.88, pp.61-70, 2013. ,
Peripheral gating of pain signals by endogenous lipid mediators, Nat Neurosci, vol.17, pp.164-174, 2014. ,
A lipid gate for the peripheral control of pain, J Neurosci, vol.34, pp.15184-15191, 2014. ,
Mode of action of mood stabilizers: is the arachidonic acid cascade a common target? Mol Psychiatry, vol.13, pp.585-596, 2008. ,
Braintargeting form of docosahexaenoic acid for experimental stroke treatment: MRI evaluation and anti-oxidant impact, Curr Neurovasc Res, vol.8, pp.95-102, 2011. ,
URL : https://hal.archives-ouvertes.fr/hal-02653073
Selective reduction of excitatory hippocampal sharp waves by docosahexaenoic acid and its methyl ester analog ex-vivo, Brain Res, vol.1537, pp.9-17, 2013. ,
Increases in seizure latencies induced by subcutaneous docosahexaenoic acid are lost at higher doses, Epilepsy Res, vol.99, pp.225-232, 2012. ,
Type-1 cannabinoid receptor signaling in neuronal development, Pharmacology, vol.90, pp.19-39, 2012. ,
Cannabinoidinduced actomyosin contractility shapes neuronal morphology and growth, Elife, vol.3, p.3159, 2014. ,
URL : https://hal.archives-ouvertes.fr/inserm-01356874